The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sheptulin V.A.

Research Institute of Eye Diseases

Fedorov A.A.

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Kovrigina A.M.

National Medical Research Center of Hematology

Lazuk A.V.

Tula State University

Grusha Y.O.

I.M. Sechenov First Moscow State Medical University (Sechenov University);
Krasnov Research Institute of Eye Diseases

Granulomatous inflammation of the orbit as a complication of stem cells injection (case study)

Authors:

Sheptulin V.A., Fedorov A.A., Kovrigina A.M., Lazuk A.V., Grusha Y.O.

More about the authors

Journal: Russian Annals of Ophthalmology. 2021;137(6): 94‑98

DOI: 10.17116/oftalma202113706194

Read: 1249 times

Download PDF (RU)
Contact the author
Table of contents

GRANULOMATOUS INFLAMMATION OF THE ORBIT AS A COMPLICATION OF STEM CELLS INJECTION (CASE STUDY)
GRANULOMATOUS INFLAMMATION OF THE ORBIT AS A COMPLICATION OF STEM CELLS INJECTION (CASE STUDY)

To cite this article:

Sheptulin VA, Fedorov AA, Kovrigina AM, Lazuk AV, Grusha YO. Granulomatous inflammation of the orbit as a complication of stem cells injection (case study). Russian Annals of Ophthalmology. 2021;137(6):94‑98. (In Russ.)
https://doi.org/10.17116/oftalma202113706194

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Arti­ficial inte­lligence in asse­ssment of indi­vidual risks of age-related macu­lar dege­neration progression. Russian Annals of Ophthalmology. 2025;(2):123-128
Mono­cyte telo­mere length as a novel biomarker of macu­lar atro­phy and response to anti-VEGF therapy in age-related macu­lar dege­neration. Russian Annals of Ophthalmology. 2025;(6):52-61
Use of fari­cimab in neovascular age-related macu­lar dege­neration and diabetic macu­lar edema in Russia. Resu­lts of the FARWATER retrospective study. Russian Annals of Ophthalmology. 2025;(6):82-91
Tolosa—Hunt syndrome. Russian Annals of Ophthalmology. 2025;(6):114-118
Auto­logous adipose-derived stem cells for the treatment of complex cryptoglandular fistula (systematic review and meta-analysis). Plastic Surgery and Aesthetic Medi­cine. 2025;(2):117-127
Towa­rds highly precise treatment and reha­bilitation in practice of modern cardiologist, cardiac surgeon and cardiac reha­bilitation professional. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):343-350
Pote­ntial and prospects of the astragaloside IV use for age-associated diseases prevention. Russian Journal of Preventive Medi­cine. 2025;(7):94-99
The type 1 diabetes mellitus treatment. Russian Journal of Preventive Medi­cine. 2025;(8):131-137
Amyloidogenesis and neurotrophic dysfunction in age-related macu­lar dege­neration in correlation with Alzheimer’s disease. Russian Journal of Archive of Pathology. 2025;(6):61-68
Biomarkers of aging mechanisms. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5-2):108-119
Abstract:

The article present a case report of orbital granulomatous inflammation after a retrobulbar injection of allogenous stem cells. Experimental treatment resulted in an orbital tumor that required surgical excision. Lymphogranulomatous inflammation with a secondary abscess was verified by morphological and immunohistochemical analyses. This case demonstrates the possible dangerous complications of the “off-label” therapy amid the rising popularity of stem cells treatment.

Keywords:

stem cells
orbital tumor
age-related macular degeneration
granulomatous inflammation

Authors:

Sheptulin V.A.

Research Institute of Eye Diseases

Fedorov A.A.

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Kovrigina A.M.

National Medical Research Center of Hematology

Lazuk A.V.

Tula State University

Grusha Y.O.

I.M. Sechenov First Moscow State Medical University (Sechenov University);
Krasnov Research Institute of Eye Diseases

Received:

12.02.2021

Accepted:

28.09.2021

Close metadata

References:

  1. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726-736.  https://doi.org/10.1038/nri2395
  2. Harklin D, Foyn L, Bray L, Sutheland A. Concise Reviews: Can Mesenchymal Stromal Cells Differentiate into Corneal Cells? A Systematic Review of Published Data. Stem Cells. 2015;33:785-791.  https://doi.org/10.1002/stem.1895
  3. Ke Y, Wu Y, Cui X. Polysaccharide Hydrogel Combined with Mesenchymal Stem Cells Promotes the Healing of Corneal Alkali Burn in Rats. PLoS One. 2015;19:1-18.  https://doi.org/10.1371/journal.pone.0119725
  4. Villatoro A, Fernández V, Claros S. Use of Adipose-Derived Mesenchymal Stem Cells in Keratoconjunctivitis Sicca in a Canine Model. BioMed Res Int. 2015. Article ID 527926, 10 p.  https://doi.org/10.1155/2015/527926
  5. Omoto M, Katikireddy K, Rezazadeh A. Mesenchymal stem cells home to inflamed ocular surface and suppress allosensitization in corneal transplantation. Invest Ophthalmol Vis Sci. 2014;55:6631-6638. https://doi.org/10.1167/iovs.14-15413
  6. Hong H, Samuel CY. Stem cell-based therapy for treating limbal stem cells deficiency: A review of different strategies. Saudi J Ophthalmol. 2014;28(3): 188-194.  https://doi.org/10.1016/j.sjopt.2014.06.003
  7. Kulikov AN, Churashov SV, Chernysh VF, Blinova MI, Aleksandrova OI, Karpovich VV, Khorol’skaya YuI. Current approaches to the problem of carrier selection for limbal stem cells cultivation in the treatment of limbal stem cell deficiency. Ophthalmology Journal = Oftal’mologicheskiye vedomosti. 2018;11(2):48-56. (In Russ.). https://doi.org/10.17816/OV11248-56
  8. Chentsova EV, Pak NV, Zueva MV, Tsapenko IV, Poltavtseva RA, Aleksandrova MA, Sukhikh GT. The influence of neural stem cell transplantation on the processes of retinal regeneration in experiment. Rossiiskii oftal’mologicheskii zhurnal. 2012;5(4):83-88. (In Russ.).
  9. Gundorova RA, Chentsova EV. Cellular technologies in ophthalmology: 10 years of experimental research experience and clinical prospects. Rossiiskii oftal’mologicheskii zhurnal. 2008;1(1):45-49. (In Russ.).
  10. Sarawut S, Parinya N. Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases. World Stem Cells. 2015;7(2): 502-511.  https://doi.org/10.4252/wjsc.v7.i2.502
  11. Neroeva NV, Neroev VV, Katargina LA. Method for subretinal transplantation of retinal pigment epithelium (RPE) cells differentiated from induced human pluripotent stem cells in atrophy of retinal pigment epithelium. RF patent for invention No. 2730937/26.08.2020. Bull. No. 24. Accessed 26.08.2020. (In Russ.). https://i.moscow/patents/RU2729937C1_20200813
  12. Duan P, Xu H, Zeng Y, Wang Y, Yin ZQ. Human bone marrow stromal cells can differentiate to a retinal pigment epithelial phenotype when co-cultured with pig retinal pigment epithelium using a transwell system. Cell Physiol Biochem. 2013;31:601-613.  https://doi.org/10.1159/000350080
  13. Gong L, Wu Q, Song B, Lu B, Zhang Y. Differentiation of rat mesenchymal stem cells transplanted into the subretinal space of sodium iodate injected rats. Clin Exper Ophthalmol. 2008;36:666-671.  https://doi.org/10.1111/j.1442-9071.2008.01857.x
  14. Li N, Li X, Yuan J. Effects of bone-marrow mesenchymal stem cells transplanted into the vitreous cavity of rat injured by ischemia/reperfusion. Graefes Arch Clin Exp Ophthalmol. 2009;247:503-514.  https://doi.org/10.1007/s00417-008-1009-y
  15. Parr AM, Tator CH, Keating A. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002;416:542-545. 
  16. Tzameret A, Sher I, Belkin M, Treves AJ, Meir A, Nagler A, Levkovitch-Verbin H, Barshack I, Rosner M, Rotenstreich Y. Transplantation of human bone marrow mesenchymal stem cells as a thin subretinal layer ameliorates retinal degeneration in a rat model of retinal dystrophy. Exp Eye Res. 2014; 118:135-144.  https://doi.org/10.1016/j.exer.2013.10.023
  17. Arnhold S, Absenger Y, Klein H, Addicks K, Schraermeyer U. Transplantation of bone marrow-derived mesenchymal stem cells rescue photoreceptor cells in the dystrophic retina of the rhodopsin knockout mouse. Graefes Arch Clin Exp Ophthalmol. 2007;245:414-422.  https://doi.org/10.1007/s00417-006-0382-7
  18. Leow S, Luu C, Hairul Nizam M. Safety and Efficacy of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells Therapy for Retinal Degeneration. PLoS One. 2015;10(6):1-20.  https://doi.org/10.1371/journal.pone.0128973
  19. Cerman E, Akkoc T, Eraslan M, Sahin O, Ozkara S, Vardar Aker F, Subasi C, Karaoz E, Akkoc T. Retinal electrophysiological effects of intravitreal bone marrow derived mesenchymal stem cells in streptozotocin induced diabetic rats. PLoS One. 2016;11(6):e0156495. https://doi.org/10.1371/journal.pone.0156495
  20. Weiss JN, Levy S. Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow derived stem cells in the treatment of Dominant Optic Atrophy. Stem Cell Investig. 2019;6:41.  https://doi.org/10.21037/sci.2019.11.01
  21. Weiss JN, Levy S, Malkin A. Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a preliminary report. Neural Regen Res. 2015;10(6):982-988.  https://doi.org/10.4103/1673-5374
  22. Suzuki K, Sun R, Origuchi M, Kanehira M, Takahata T, Itoh J, Umezawa A, Kijima H, Fukuda S, Saijo Y. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med. 2011;17(7-8):579-587.  https://doi.org/10.2119/molmed.2010.00157
  23. Musiał-Wysocka A, Kot M, Majka M. The Pros and Cons of Mesenchymal Stem Cell-Based Therapies. Cell Transplant. 2019;28(7):801-812.  https://doi.org/10.1177/0963689719837897
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.